Provider-supervised medical weight loss in Lincoln, NE — using FDA-approved GLP-1 medications, comprehensive lab work, and ongoing clinical oversight to support sustainable results.
Not sure where to start? Take the 60-second fit quiz — it matches your symptoms to the right therapy.
You do not need to know whether semaglutide, tirzepatide, hormone support, or nutrition changes are the right fit yet. Revi starts with labs, then builds the plan around what your body is actually showing.
Take the fit quiz and get pointed toward the best starting conversation.
The right plan depends on hormones, thyroid, metabolism, and what your body is actually showing.
Revi pairs medical weight loss with body-composition and nutrition perspective.
Stubborn weight rarely responds to willpower alone, especially in your late 30s, 40s, and 50s. The hormonal, metabolic, and signaling shifts that accumulate with age change how your body responds to the same inputs. Medical weight loss therapy can help — when it's used as part of a comprehensive plan, not as a shortcut.
At Revi, semaglutide and tirzepatide are part of the toolkit when clinically indicated. They are not the whole answer. We use them under provider supervision, alongside lab-based assessment of the underlying drivers (thyroid, hormones, metabolic function, inflammation) and an in-house nutrition perspective most weight loss clinics don't have.
A GLP-1 receptor agonist medication. The active ingredient in Wegovy and Ozempic (FDA-approved). Used to support appetite regulation, satiety, and metabolic function as part of a comprehensive medical weight loss plan.
A dual GIP/GLP-1 receptor agonist. The active ingredient in Mounjaro and Zepbound (FDA-approved). Acts on two metabolic pathways simultaneously — supports appetite regulation, insulin response, and weight loss outcomes.
Both medications can be prescribed as the FDA-approved branded versions or, in some cases, as compounded preparations through licensed 503A compounding pharmacies. Your provider discusses which option is appropriate for your case based on availability, cost, dosing requirements, and your individual situation.
Patterns we commonly see in patients who benefit from medical weight loss therapy:
We're not the right clinic if you're looking for a 15-minute video call and a prescription with no labs. Several reputable national chains operate that way. We work differently because the underlying drivers of stubborn weight are individual, and the right treatment depends on what your labs actually show.
The same process for every medical weight loss patient at Revi.
1. Comprehensive labs before your first visit. Hormone panel, thyroid, metabolic markers (insulin, glucose, HbA1c, lipids), inflammation indicators. Your consultation begins with real data.
2. Medical review with the clinical team. Your labs, weight history, metabolic markers, medical history, and goals are reviewed together. The clinical team determines whether GLP-1 therapy is appropriate and what supporting therapies may be useful.
3. Personalized treatment plan. GLP-1 selection (semaglutide or tirzepatide), dose, escalation schedule, and supporting interventions (hormone therapy, peptide support for body composition, nutrition guidance) are matched to your individual case.
4. Ongoing monitoring. Regular check-ins, follow-up labs, dose adjustments, side effect management, and integration with the broader physiological picture. Your protocol evolves as your body responds.
"Medications can change the playing field. They can't replace the fundamentals — protein intake, resistance training, sleep, and consistency. The clients who do best on GLP-1 therapies are the ones who use the appetite-regulating window to build sustainable habits, not the ones who treat the medication as the whole answer." — Steve Lucchino, Cofounder, Revi 18+ years in nutrition and supplement industry. Macro-based nutrition coach to 100+ clients. Read full bio →
This is part of why provider-supervised, multi-disciplinary medical weight loss tends to outperform telehealth-only GLP-1 prescriptions over the long term. Weight management isn't just a prescription decision — it's a coordinated plan.
We discuss the specifics during your consultation. Both FDA-approved branded versions and compounded preparations exist; the appropriate choice depends on availability, cost, dosing requirements, and your individual case. Your provider will explain the options and the regulatory context for each.
Initial appetite changes often start within the first week. Meaningful weight loss typically begins within the first month and continues over 6-12 months as the dose is titrated to your response. Your provider sets specific expectations based on your starting point and goals.
GLP-1 medications can cause nausea, gastrointestinal symptoms, constipation, and reduced appetite, especially during dose escalation. Most side effects are dose-related and improve with adjustment. Less common but more serious side effects (pancreatitis, gallbladder issues, thyroid concerns in patients with personal/family history of medullary thyroid carcinoma) are reviewed during your consultation. Tell your provider about any history of pancreatitis, gallbladder disease, or relevant family history.
Highly individual. Some patients use it for 6-12 months alongside lifestyle changes, then taper. Others remain on a maintenance dose long-term. Your provider plans the duration with you and reviews periodically.
Without continued lifestyle support, weight regain is common after stopping GLP-1 therapy. The medication shifts appetite and metabolic regulation while you take it; when you stop, those signals return to baseline. Sustainable results depend on building habits during the medication window — which is part of why we build nutrition support into our medical weight loss plans.
Yes, and many patients do. The two often work together — hormones address the foundational endocrine picture; GLP-1s address appetite and metabolic regulation.
Because the underlying drivers of stubborn weight (thyroid, insulin resistance, hormonal shifts, inflammation) are individual, and the right treatment depends on what your labs actually show. Skipping labs means skipping the diagnostic step that distinguishes "GLP-1 is the right tool" from "GLP-1 is part of a bigger plan."
Costs vary by medication, dose, pharmacy, labs, and follow-up needs. We discuss pricing during your consultation before treatment begins.
Then we don't recommend it. Some patients have contraindications; others respond better to hormone optimization, metabolic support, or other approaches. Your labs and history guide the conversation; not every patient leaves with a GLP-1 prescription.
Owner and Medical Director. Board-certified interventional radiologist with 20+ years of experience.
Read full bio →